Results

eNauka >  Results >  Efficacy of Guselkumab in Moderately to Severely Active Crohn's Disease According to Induction Clinical Response Status: Week 48 Results from the GALAXI 2 & 3 Phase 3 Trials
Title: Efficacy of Guselkumab in Moderately to Severely Active Crohn's Disease According to Induction Clinical Response Status: Week 48 Results from the GALAXI 2 & 3 Phase 3 Trials
Authors: Afzali, Anita; Panes, Julian; Sands, Bruce E; Rubin, David T; Panaccione, Remo; Terry, Natalie A; Salese, Leonardo; Van, Rampelbergh Rian; Yang, Zijiang; Frustaci, Mary Ellen;
Tarabar, Dino K; Chen, Minhu; Mihaly, Emese; Wolf, Douglas; D'Haens, Geert R;
Issue Date: 2024
Publication: AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN: 0002-9270 American Journal of Gastroenterology Search Idenfier
Type: Conference Paper
Collation: vol. 119 br. 10S str. S1024-S1025
DOI: 10.14309/01.ajg.0001035084.95280.e1
WoS-ID: 001359341300005
URI: https://enauka.gov.rs/handle/123456789/952780
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.